Target deconvolution of bioactive small molecules

The heart of chemical biology and drug discovery

Hye Jin Jung, Ho Jeong Kwon

Research output: Contribution to journalReview article

21 Citations (Scopus)

Abstract

Identification of the target proteins of bioactive small molecules isolated from phenotypic screens plays an important role in chemical biology and drug discovery. However, discovering the targets of small molecules is often the most challenging and time-consuming step for chemical biology researchers. To overcome the bottlenecks in target identification, many new approaches based on genomics, proteomics, and bioinformatics technologies have been developed. Here, we provide an overview of the current major methodologies for target deconvolution of bioactive small molecules. To obtain an integrated view of the mechanisms of action of small molecules, we propose a systematic approach that involves the combination of multi-omics-based target identification and validation and preclinical target validation.

Original languageEnglish
Pages (from-to)1627-1641
Number of pages15
JournalArchives of Pharmacal Research
Volume38
Issue number9
DOIs
Publication statusPublished - 2015 Sep 22

Fingerprint

Deconvolution
Drug Discovery
Molecules
Genomics
Computational Biology
Proteomics
Research Personnel
Technology
Bioinformatics
Proteins

All Science Journal Classification (ASJC) codes

  • Molecular Medicine
  • Drug Discovery
  • Organic Chemistry

Cite this

@article{417843f4c3504d92b9ebd2874ffe7c53,
title = "Target deconvolution of bioactive small molecules: The heart of chemical biology and drug discovery",
abstract = "Identification of the target proteins of bioactive small molecules isolated from phenotypic screens plays an important role in chemical biology and drug discovery. However, discovering the targets of small molecules is often the most challenging and time-consuming step for chemical biology researchers. To overcome the bottlenecks in target identification, many new approaches based on genomics, proteomics, and bioinformatics technologies have been developed. Here, we provide an overview of the current major methodologies for target deconvolution of bioactive small molecules. To obtain an integrated view of the mechanisms of action of small molecules, we propose a systematic approach that involves the combination of multi-omics-based target identification and validation and preclinical target validation.",
author = "Jung, {Hye Jin} and Kwon, {Ho Jeong}",
year = "2015",
month = "9",
day = "22",
doi = "10.1007/s12272-015-0618-3",
language = "English",
volume = "38",
pages = "1627--1641",
journal = "Archives of Pharmacal Research",
issn = "0253-6269",
publisher = "Pharmaceutical Society of Korea",
number = "9",

}

Target deconvolution of bioactive small molecules : The heart of chemical biology and drug discovery. / Jung, Hye Jin; Kwon, Ho Jeong.

In: Archives of Pharmacal Research, Vol. 38, No. 9, 22.09.2015, p. 1627-1641.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Target deconvolution of bioactive small molecules

T2 - The heart of chemical biology and drug discovery

AU - Jung, Hye Jin

AU - Kwon, Ho Jeong

PY - 2015/9/22

Y1 - 2015/9/22

N2 - Identification of the target proteins of bioactive small molecules isolated from phenotypic screens plays an important role in chemical biology and drug discovery. However, discovering the targets of small molecules is often the most challenging and time-consuming step for chemical biology researchers. To overcome the bottlenecks in target identification, many new approaches based on genomics, proteomics, and bioinformatics technologies have been developed. Here, we provide an overview of the current major methodologies for target deconvolution of bioactive small molecules. To obtain an integrated view of the mechanisms of action of small molecules, we propose a systematic approach that involves the combination of multi-omics-based target identification and validation and preclinical target validation.

AB - Identification of the target proteins of bioactive small molecules isolated from phenotypic screens plays an important role in chemical biology and drug discovery. However, discovering the targets of small molecules is often the most challenging and time-consuming step for chemical biology researchers. To overcome the bottlenecks in target identification, many new approaches based on genomics, proteomics, and bioinformatics technologies have been developed. Here, we provide an overview of the current major methodologies for target deconvolution of bioactive small molecules. To obtain an integrated view of the mechanisms of action of small molecules, we propose a systematic approach that involves the combination of multi-omics-based target identification and validation and preclinical target validation.

UR - http://www.scopus.com/inward/record.url?scp=84941992624&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84941992624&partnerID=8YFLogxK

U2 - 10.1007/s12272-015-0618-3

DO - 10.1007/s12272-015-0618-3

M3 - Review article

VL - 38

SP - 1627

EP - 1641

JO - Archives of Pharmacal Research

JF - Archives of Pharmacal Research

SN - 0253-6269

IS - 9

ER -